BACKGROUND: It has been suggested that the genetically determined deficiency of glutathione S transferase (GST) enzymes involved in the detoxification of environmental tobacco smoke (ETS) components may contribute to the development of asthma. METHODS: A large population of German schoolchildren (n = 3054) was genotyped for deficiencies of the GST isoforms M1 and T1. The association between GSTM1 and GSTT1 genotypes and asthma as well as atopy was investigated with respect to current and in utero ETS exposure. RESULTS: In children lacking the GSTM1 allele who were exposed to current ETS the risk for current asthma (OR 5.5, 95% CI 1.6 to 18.6) and asthma symptoms such as wheeze ever (OR 2.8, 95% CI 1.3 to 6.0), current wheezing (OR 4.7, 95% CI 1.8 to 12.6) and shortness of breath (OR 8.9, 95% CI 2.1 to 38.4) was higher than in GSTM1 positive individuals without ETS exposure. Hints of an interaction between ETS exposure and GSTM1 deficiency were identified. In utero smoke exposure in GSTT1 deficient children was associated with significant decrements in lung function compared with GSTT1 positive children not exposed to ETS. CONCLUSIONS: GSTM1 and GSTT1 deficiency may increase the adverse health effects of in utero and current smoke exposure.
BACKGROUND: It has been suggested that the genetically determined deficiency of glutathione S transferase (GST) enzymes involved in the detoxification of environmental tobacco smoke (ETS) components may contribute to the development of asthma. METHODS: A large population of German schoolchildren (n = 3054) was genotyped for deficiencies of the GST isoforms M1 and T1. The association between GSTM1 and GSTT1 genotypes and asthma as well as atopy was investigated with respect to current and in utero ETS exposure. RESULTS: In children lacking the GSTM1 allele who were exposed to current ETS the risk for current asthma (OR 5.5, 95% CI 1.6 to 18.6) and asthma symptoms such as wheeze ever (OR 2.8, 95% CI 1.3 to 6.0), current wheezing (OR 4.7, 95% CI 1.8 to 12.6) and shortness of breath (OR 8.9, 95% CI 2.1 to 38.4) was higher than in GSTM1 positive individuals without ETS exposure. Hints of an interaction between ETS exposure and GSTM1 deficiency were identified. In utero smoke exposure in GSTT1 deficient children was associated with significant decrements in lung function compared with GSTT1 positive children not exposed to ETS. CONCLUSIONS:GSTM1 and GSTT1 deficiency may increase the adverse health effects of in utero and current smoke exposure.
Authors: Michael Kabesch; Wilfried Peters; David Carr; Wolfgang Leupold; Stephan K Weiland; Erika von Mutius Journal: J Allergy Clin Immunol Date: 2003-04 Impact factor: 10.793
Authors: D Ryberg; V Skaug; A Hewer; D H Phillips; L W Harries; C R Wolf; D Ogreid; A Ulvik; P Vu; A Haugen Journal: Carcinogenesis Date: 1997-07 Impact factor: 4.944
Authors: J Genuneit; G Weinmayr; K Radon; H Dressel; D Windstetter; P Rzehak; C Vogelberg; W Leupold; D Nowak; E von Mutius; S K Weiland Journal: Thorax Date: 2006-03-14 Impact factor: 9.139
Authors: David Itiro Kasahara; Matthew E Poynter; Ziryan Othman; David Hemenway; Albert van der Vliet Journal: J Immunol Date: 2008-07-01 Impact factor: 5.422
Authors: Jackie K W Chan; Sean D Kodani; Jessie G Charrier; Dexter Morin; Patricia C Edwards; Donald S Anderson; Cort Anastasio; Laura S Van Winkle Journal: Am J Respir Cell Mol Biol Date: 2012-10-11 Impact factor: 6.914